Table 4.
Results of the Sensitivity Tests for MDR Kl. pneumoniae.
| 1 | 2 | ||
|---|---|---|---|
| Department | ICU | ICU | |
| Location | Isolated room | Isolated room | |
| Antibiotics | Aminoglycosides | R | R |
| Antipseudomonal penicillins and b-lactamase inhibitors | R | R | |
| Carbapenems | R | R | |
| Non-extended spectrum cephalosporins, 1st and 2nd generation cephalosporins | R | R | |
| Extended-spectrum cephalosporins; 3rd and 4th generation cephalosporins | R | R | |
| Cephamycins | R | R | |
| Fluoroquinolones | R | R | |
| Folate pathway inhibitors | R | R | |
| Glycylcyclines | S | S | |
| Monobactams | R | R | |
| Penicillins | R | R | |
| Penicillins + b-lactamase inhibitors | R | R | |
| Phenicols | S | S | |
| Phosphonic acids | S | S | |
| Polymyxins | S | S | |
| Tetracyclines | S | S | |
| Resistance type | MDR | MDR | |